L1CAM and endometrium neoplasm: The IHC detection of L1CAM in endometrial tumour samples is able to discriminate a subset of highly aggressive tumours with adverse clinical outcome and high risk of distant recurrences, and to assess the risk of pelvic lymph-node involvement.